IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novelion Therapeutics Inc COM New

CUSIP: 067001K10 | 2 institutional holders

Quarters

Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2019

Financial Gravity Wealth, Inc.8
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Financial Gravity Wealth, Inc.
8$00.0%GrowthVery LowAllen, TX2019-10-15